KetCRPS-2

Phase 1

• Conditions: Complex regional pain syndrome; MedDRA version: 21.1Level: PTClassification code: 10064332Term: Complex regional pain syndrome Class: 100000004852; Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]

• Registration Number: CTIS2024-511877-31-00
• Lead Sponsor: Erasmus Universitair Medisch Centrum Rotterdam (Erasmus MC)

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2024-04-10
• Last Update Posted: 22 July 2024

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 60

Inclusion Criteria

Age = 18 years, Meeting the new International Association for the Study of Pain (IASP) diagnostic criteria for CRPS (the Budapest Criteria) or having met the new IASP diagnostic criteria of CRPS (CRPS with Remission of Some features”), Willing and capable to participate in the study., CRPS in one upper extremity and/or CRPS in one lower extremity, Treatment in an elective setting, Adequate comprehension of the Dutch language

Exclusion Criteria

Contraindications to and precautions for use of subanesthetic doses of ketamine for chronic pain are listed by Cohen et al. and the Dutch CRPS guidelines and our clinical protocol

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified